Jasna Križ

NeuroscienceMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Prion protein lowering is a disease-modifying therapy across prion disease stages, strains and endpoints”.

Prion protein lowering is a disease-modifying therapy across prion disease stages, strains and endpoints

Nucleic Acids Research(2020)10.1093/nar/gkaa616

N/A

0DataRank · unranked

144 citations

Hien Zhao, Jason Le, Jill O’Moore, Rose Pitstick, Samantha Graffam +19 more

Therapeutic trial of anle138b in mouse models of genetic prion disease

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.10.11.511739

N/A

0DataRank · unranked

1 citations

Dan Zou, Rose Pitstick, Jill O’Moore, Janet Peters, Derek Silvius +6 more

Therapeutic Trial of anle138b in Mouse Models of Genetic Prion Disease

Journal of Virology(2023)10.1128/jvi.01672-22

N/A

0DataRank · unranked

17 citations

Dan Zou, Rose Pitstick, Jill O’Moore, Janet Peters, Derek Silvius +6 more

CD36 neutralisation blunts TLR2-IRF7 but not IRF3 pathway in neonatal mouse brain and immature human microglia following innate immune challenge

Scientific Reports(2023)10.1038/s41598-023-29423-0

N/A

0DataRank · unranked

7 citations

Mélanie Lalancette–Hébert, Sai Sampath Thammisetty, Zinaida S. Vexler, Jasna Križ, Shruti Gururaj Gadagkar